EFM
PRAX icon

E Fund Management’s Praxis Precision Medicines PRAX Stock Holding History

E Fund Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$564K Sell
1,684
-272
-14% -$86.1K 0.01% 242
2026
Q1 		$630K Buy
+1,956
New +$605K 0.02% 235
2022
Q3 		– Sell
-1,738
Closed -$64K – 341
2022
Q2 		$64K Buy
+1,738
New +$185K 0.01% 320

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

E Fund Management's PRAX Position: Q2 2026 in Review

E Fund Management reduced its Praxis Precision Medicines (PRAX) stake by 14% in Q2 2026, selling an estimated $86.1K and leaving 1,684 shares worth $564K. The position accounts for 0.01% of the portfolio, ranked #242.

E Fund Management first reported a position in PRAX in Q2 2022 and has held it in 3 quarters since. The position peaked at $630K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • E Fund Management held 1,684 shares of Praxis Precision Medicines worth $564K as of Q2 2026.
  • E Fund Management sold 272 Praxis Precision Medicines shares in Q2 2026, an estimated $86.1K.
  • Praxis Precision Medicines made up 0.01% of E Fund Management's portfolio in Q2 2026, its #242 holding.
  • E Fund Management first reported a position in Praxis Precision Medicines in Q2 2022 and has held it in 3 quarters since.
  • E Fund Management's Praxis Precision Medicines position peaked at $630K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.